Daniel Humer, PA
Physician Assistant · Lone Tree, CONPI 1003053554
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 67.3% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $38,257, more than ten times the $1,203 reported in 2021. Among physician assistant clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $200.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$47K
- Janssen Scientific Affairs, LLC$7K
- Dendreon Pharmaceuticals LLC$5K
- Accord Healthcare, Inc.$3K
- Urogen Pharma, Inc.$1K
- Astellas Pharma US Inc$1K
- plus $6K from 25 others
What the payments were for
- Consulting fees$15,60123%
- Speaking & faculty fees$37,19054%
- Travel & lodging$3,3985%
- Food & beverage$12,23418%
- Education$9151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 119 | $46,690 |
| Janssen Scientific Affairs, LLC | 9 | $6,981 |
| Dendreon Pharmaceuticals LLC | 29 | $4,636 |
| Accord Healthcare, Inc. | 9 | $3,103 |
| Urogen Pharma, Inc. | 5 | $1,089 |
| Astellas Pharma US Inc | 29 | $1,085 |
| Ferring Pharmaceuticals Inc. | 3 | $830 |
| Bayer | 16 | $569 |
| Myovant Sciences Inc. | 22 | $485 |
| E.r. Squibb & Sons, L.L.C. | 2 | $476 |
| Novartis | 8 | $469 |
| Sumitomo Pharma America, Inc. | 19 | $454 |
| Pfizer | 20 | $420 |
| Boston Scientific | 6 | $350 |
| Medtronic | 3 | $280 |
| Merck | 7 | $231 |
| Axonics, Inc. | 9 | $207 |
| AbbVie(2 entities) | 11 | $191 |
| Olympus America Inc. | 2 | $136 |
| AstraZeneca | 2 | $133 |
| Progenics Pharmaceuticals, Inc. | 2 | $87 |
| Amgen | 1 | $82 |
| Endo Pharmaceuticals Inc. | 1 | $81 |
| Tolmar, Inc. | 1 | $79 |
| Antares Pharma, Inc. | 2 | $38 |
| Foundation Medicine, Inc. | 2 | $36 |
| ABC Home Medical Supply, Inc. | 1 | $26 |
| 180 Medical, Inc. | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 2 | $24 |
| Coloplast | 1 | $23 |
| Teleflex LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$69,339 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 101 | $1,413,263 |
| ErleadaApalutamide | 49 | $711,150 |
| OrgovyxRelugolix | 95 | $265,337 |
| Abiraterone Acetate | 47 | $92,287 |
| GemtesaVibegron | 17 | $21,853 |
| MyrbetriqMirabegron | 17 | $20,964 |
| Tamsulosin Hcl | 104 | $1,409 |
| Finasteride | 62 | $1,062 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $476 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 26 | $305 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $226 |
| Prednisone | 47 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $131 |
| Cephalexin | 11 | $127 |
| Ondansetron OdtOndansetron | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $1,085 | $1,434,227118 claims |
| Johnson & JohnsonErleada | $46,690 | $711,15049 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $454 | $287,191112 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $6,981 | $92,28747 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Lone Tree
- Julie MessinaLone Tree$13K
- Andrew RamirezLone Tree$13K
- Kelly SmeesterLone Tree$12K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.